Polaryx Therapeutics Inc:持续积极携手合同研究机构推进2026年上半年启动临床试验计划

美股速递
Feb 17

Polaryx Therapeutics Inc(简称PLYX)近日透露,公司正与其合同研究机构(CRO)保持紧密合作,全力推进相关临床试验的筹备工作。根据最新规划,该项试验预计将于2026年上半年正式启动。

目前,双方团队正就试验方案设计、监管审批流程及执行细节等关键环节进行深入协调。这一进展标志着Polaryx Therapeutics Inc在创新药物研发领域迈出重要一步。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10